Revolution Medicines, Inc. <RVMD.O>: H.C. Wainwright raises target price to $280 from $195
RVMD•Related News
Barrel Energy issues $200,000 6% convertible note to CFI Capital LLC under private placement
BRLL•
Baozun Q2 FY26 net income turns to RMB 17 million; revenue rises 7.5% to RMB 2.74 billion
BZUN•
Toronto-Dominion Bank Q3 Adjusted EPS CAD 2.77 Vs. IBES Estimate CAD 2.47
TD•
Odyssey Therapeutics, Inc. <ODTX.O>: H.C. Wainwright initiates coverage with buy rating and target price $44
ODTX•
Canada's Canadian Solar Q2 revenue beats, helped by strength in energy storage shipments
CSIQ•